Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial have?
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial has 43 citations in the OpenAlex counts ScholarIQ stores.
When was Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial published?
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial has 2025 year in the ScholarIQ index.
What is the open-access status of Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial has green oa status in the ScholarIQ index.
What is the DOI of Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The DOI for Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.
What is the PMID of Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The PMID for Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.
What is the OpenAlex record for Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The OpenAlex for Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.